IBB: Beyond The 2025 Surge, Biotech Breakout
Source: SeekingAlpha
2026-01-27 05:10:39 ET
After a multi-year drought, the iShares Biotechnology ETF ( IBB ) has been quietly having a fantastic run, returning about 28% for 2025, dwarfing its modest returns in 2023, alongside losses in 2022, 2024, amid a renewed risk appetite, a healthy environment of IPO & M&A activity, alongside a sturdy show by large-cap biotechs, where IBB derives its weights from....
Read the full article on Seeking Alpha
For further details see:
IBB: Beyond The 2025 Surge, Biotech Breakout
First Trust Amex Biotech Index Fund
NASDAQ: FBT
FBT Trading
1.14% G/L:
$198.71 Last:
16,856 Volume:
$196.36 Open:
